AAAAAA
Results: 1-25/38
Authors:
OHH M
YAUCH RL
LONERGAN KM
WHALEY JM
STEMMERRACHAMIMOV AO
LOUIS DN
GAVIN BJ
KLEY N
KAELIN WG
ILIOPOULOS O
Citation: M. Ohh et al., THE VON-HIPPEL-LINDAU TUMOR-SUPPRESSOR PROTEIN IS REQUIRED FOR PROPERASSEMBLY OF AN EXTRACELLULAR FIBRONECTIN MATRIX, MOLECULAR CELL, 1(7), 1998, pp. 959-968
Authors:
KAELIN WG
ILIOPOULOS O
LONERGAN KM
OHH M
Citation: Wg. Kaelin et al., FUNCTIONS OF THE VON-HIPPEL-LINDAU TUMOR-SUPPRESSOR PROTEIN, Journal of internal medicine, 243(6), 1998, pp. 535-539
Authors:
SELLERS WR
NOVITCH BG
MIYAKE S
HEITH A
OTTERSON GA
KAYE FJ
LASSAR AB
KAELIN WG
Citation: Wr. Sellers et al., STABLE BINDING TO E2F IS NOT REQUIRED FOR THE RETINOBLASTOMA PROTEIN TO ACTIVATE TRANSCRIPTION, PROMOTE DIFFERENTIATION, AND SUPPRESS TUMOR-CELL GROWTH, Genes & development, 12(1), 1998, pp. 95-106
Authors:
LONERGAN KM
ILIOPOULOS O
OHH M
KAMURA T
CONAWAY RC
CONAWAY JW
KAELIN WG
Citation: Km. Lonergan et al., REGULATION OF HYPOXIA-INDUCIBLE MESSENGER-RNAS BY THE VON-HIPPEL-LINDAU TUMOR-SUPPRESSOR PROTEIN REQUIRES BINDING TO COMPLEXES CONTAINING ELONGINS B C AND CUL2/, Molecular and cellular biology, 18(2), 1998, pp. 732-741
Authors:
MARIN MC
JOST CA
IRWIN MS
DECAPRIO JA
CAPUT D
KAELIN WG
Citation: Mc. Marin et al., VIRAL ONCOPROTEINS DISCRIMINATE BETWEEN P53 AND THE P53 HOMOLOG P73, Molecular and cellular biology (Print), 18(11), 1998, pp. 6316-6324
Authors:
KAELIN WG
MAHER ER
Citation: Wg. Kaelin et Er. Maher, THE VHL TUMOR-SUPPRESSOR GENE PARADIGM, Trends in genetics, 14(10), 1998, pp. 423-426
Authors:
KAELIN WG
Citation: Wg. Kaelin, CARCINOGENESIS - ANOTHER P53 DOPPELGANGER, Science, 281(5373), 1998, pp. 57-58
Authors:
ILIOPOULOS O
OHH M
KAELIN WG
Citation: O. Iliopoulos et al., PVHL(19) IS A BIOLOGICALLY-ACTIVE PRODUCT OF THE VON-HIPPEL-LINDAU GENE ARISING FROM INTERNAL TRANSLATION INITIATION, Proceedings of the National Academy of Sciences of the United Statesof America, 95(20), 1998, pp. 11661-11666
Authors:
PARR MJ
MANOME Y
TANAKA T
WEN P
KUFE DW
KAELIN WG
FINE HA
Citation: Mj. Parr et al., TUMOR-SELECTIVE TRANSGENE EXPRESSION IN-VIVO MEDIATED BY AN E2F-RESPONSIVE ADENOVIRAL VECTOR, Nature medicine, 3(10), 1997, pp. 1145-1149
Authors:
ILIOPOULOS O
KAELIN WG
Citation: O. Iliopoulos et Wg. Kaelin, THE MOLECULAR-BASIS OF VON-HIPPEL-LINDAU-DISEASE, Molecular medicine, 3(5), 1997, pp. 289-293
Authors:
KAELIN WG
Citation: Wg. Kaelin, RECENT INSIGHTS INTO THE FUNCTIONS OF THE RETINOBLASTOMA SUSCEPTIBILITY GENE-PRODUCT, Cancer investigation, 15(3), 1997, pp. 243-254
Authors:
SELLERS WR
KAELIN WG
Citation: Wr. Sellers et Wg. Kaelin, ROLE OF THE RETINOBLASTOMA PROTEIN IN THE PATHOGENESIS OF HUMAN CANCER, Journal of clinical oncology, 15(11), 1997, pp. 3301-3312
Authors:
LEVY AP
LEVY NS
ILIOPOULOS O
JIANG C
KAELIN WG
GOLDBERG MA
Citation: Ap. Levy et al., REGULATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR BY HYPOXIA AND ITS MODULATION BY THE VON-HIPPEL-LINDAU TUMOR-SUPPRESSOR GENE, Kidney international, 51(2), 1997, pp. 575-578
Authors:
CORLESS CL
KIBEL AS
ILIOPOULOS O
KAELIN WG
Citation: Cl. Corless et al., IMMUNOSTAINING OF THE VON-HIPPEL-LINDAU GENE-PRODUCT IN NORMAL AND NEOPLASTIC HUMAN TISSUES, Human pathology, 28(4), 1997, pp. 459-464
Authors:
JOST CA
MARIN MC
KAELIN WG
Citation: Ca. Jost et al., P73 IS A HUMAN P53-RELATED PROTEIN THAT CAN INDUCE APOPTOSIS, Nature, 389(6647), 1997, pp. 191-194
Authors:
MAHER ER
KAELIN WG
Citation: Er. Maher et Wg. Kaelin, VON-HIPPEL-LINDAU-DISEASE, Medicine, 76(6), 1997, pp. 381-391
Authors:
NEUMAN E
SELLERS WR
MCNEIL JA
LAWRENCE JB
KAELIN WG
Citation: E. Neuman et al., STRUCTURE AND PARTIAL GENOMIC SEQUENCE OF THE HUMAN E2F1 GENE, Gene, 173(2), 1996, pp. 163-169
Authors:
SELLERS WR
KAELIN WG
Citation: Wr. Sellers et Wg. Kaelin, RB AS A MODULATOR OF TRANSCRIPTION (VOL 1288, PG M1, 1996), Biochimica et biophysica acta, CR. Reviews on cancer, 1288(3), 1996, pp. 1-1
Authors:
SELLERS WR
KAELIN WG
Citation: Wr. Sellers et Wg. Kaelin, XRB AS A MODULATOR OF TRANSCRIPTION, Biochimica et biophysica acta, CR. Reviews on cancer, 1288(1), 1996, pp. 1-5
Authors:
ADAMS PD
SELLERS WR
SHARMA SK
WU AD
NALIN CM
KAELIN WG
Citation: Pd. Adams et al., IDENTIFICATION OF A CYCLIN-CDK2 RECOGNITION MOTIF PRESENT IN SUBSTRATES AND P21-LIKE CYCLIN-DEPENDENT KINASE INHIBITORS, Molecular and cellular biology, 16(12), 1996, pp. 6623-6633
Authors:
FIELD SJ
TSAI FY
KUO F
ZUBIAGA AM
KAELIN WG
LIVINGSTON DM
ORKIN SH
GREENBERG ME
Citation: Sj. Field et al., E2F-1 FUNCTIONS IN MICE TO PROMOTE APOPTOSIS AND SUPPRESS PROLIFERATION, Cell, 85(4), 1996, pp. 549-561
Authors:
ILIOPOULOS O
LEVY AP
JIANG C
KAELIN WG
GOLDBERG MA
Citation: O. Iliopoulos et al., NEGATIVE REGULATION OF HYPOXIA-INDUCIBLE GENES BY THE VON-HIPPEL-LINDAU PROTEIN, Proceedings of the National Academy of Sciences of the United Statesof America, 93(20), 1996, pp. 10595-10599
Authors:
GRAFI G
BURNETT RJ
HELENTJARIS T
LARKINS BA
DECAPRIO JA
SELLERS WR
KAELIN WG
Citation: G. Grafi et al., A MAIZE CDNA-ENCODING A MEMBER OF THE RETINOBLASTOMA PROTEIN FAMILY -INVOLVEMENT IN ENDOREDUPLICATION, Proceedings of the National Academy of Sciences of the United Statesof America, 93(17), 1996, pp. 8962-8967
Authors:
LOS M
JANSEN GH
KAELIN WG
LIPS CJM
BLIJHAM GH
VOEST EE
Citation: M. Los et al., EXPRESSION PATTERN OF THE VONHIPPEL-LINDAU PROTEIN IN HUMAN TISSUES, Laboratory investigation, 75(2), 1996, pp. 231-238
Authors:
KAELIN WG
Citation: Wg. Kaelin, TUMOR-SUPPRESSOR PROTEINS AS LEADING COMPOUNDS FOR DRUG DISCOVERY, British Journal of Cancer, 74, 1996, pp. 7-7